Disparities in the Treatment and Outcome of Stage I Non–Small-Cell Lung Cancer in the 21st Century

Shraddha M. Dalwadi; Gary D. Lewis; Eric H. Bernicker; Edward Brian Butler; Bin S. Teh; Andrew M. Farach

doi:10.1016/j.cllc.2018.11.004

Disparities in the Treatment and Outcome of Stage I Non–Small-Cell Lung Cancer in the 21st Century

Shraddha M. Dalwadi, Gary D. Lewis, Eric H. Bernicker, Edward Brian Butler, Bin S. Teh, Andrew M. Farach

Research output: Contribution to journal › Article

3 Scopus citations

Abstract

Racial disparities are historically profound and affect outcomes in early stage non–small-cell lung cancer. We aimed to explore if recent advances in radiotherapy and surgery have improved epidemiological differences in outcomes related to race. African American patients continued to do worse in a contemporary Surveillance, Epidemiology, and End Results data set, because of increased association with T2 disease, older age, squamous histology, male sex, and suboptimal treatment.

Original language	English (US)
Pages (from-to)	194-200
Number of pages	7
Journal	Clinical Lung Cancer
Volume	20
Issue number	3
DOIs	https://doi.org/10.1016/j.cllc.2018.11.004
State	Published - May 2019

Keywords

Access
Race
SBRT
SEER
Surgery

ASJC Scopus subject areas

Oncology
Pulmonary and Respiratory Medicine
Cancer Research

Access to Document

10.1016/j.cllc.2018.11.004

Fingerprint Dive into the research topics of 'Disparities in the Treatment and Outcome of Stage I Non–Small-Cell Lung Cancer in the 21st Century'. Together they form a unique fingerprint.

Cite this

@article{0726a4d2119f4e299d5b10984df849dd,

title = "Disparities in the Treatment and Outcome of Stage I Non–Small-Cell Lung Cancer in the 21st Century",

abstract = "Racial disparities are historically profound and affect outcomes in early stage non–small-cell lung cancer. We aimed to explore if recent advances in radiotherapy and surgery have improved epidemiological differences in outcomes related to race. African American patients continued to do worse in a contemporary Surveillance, Epidemiology, and End Results data set, because of increased association with T2 disease, older age, squamous histology, male sex, and suboptimal treatment.",

keywords = "Access, Race, SBRT, SEER, Surgery",

author = "Dalwadi, {Shraddha M.} and Lewis, {Gary D.} and Bernicker, {Eric H.} and Butler, {Edward Brian} and Teh, {Bin S.} and Farach, {Andrew M.}",

year = "2019",

month = may,

doi = "10.1016/j.cllc.2018.11.004",

language = "English (US)",

volume = "20",

pages = "194--200",

journal = "Clinical Lung Cancer",

issn = "1525-7304",

publisher = "Elsevier",

number = "3",

}

TY - JOUR

T1 - Disparities in the Treatment and Outcome of Stage I Non–Small-Cell Lung Cancer in the 21st Century

AU - Dalwadi, Shraddha M.

AU - Lewis, Gary D.

AU - Bernicker, Eric H.

AU - Butler, Edward Brian

AU - Teh, Bin S.

AU - Farach, Andrew M.

PY - 2019/5

Y1 - 2019/5

N2 - Racial disparities are historically profound and affect outcomes in early stage non–small-cell lung cancer. We aimed to explore if recent advances in radiotherapy and surgery have improved epidemiological differences in outcomes related to race. African American patients continued to do worse in a contemporary Surveillance, Epidemiology, and End Results data set, because of increased association with T2 disease, older age, squamous histology, male sex, and suboptimal treatment.

AB - Racial disparities are historically profound and affect outcomes in early stage non–small-cell lung cancer. We aimed to explore if recent advances in radiotherapy and surgery have improved epidemiological differences in outcomes related to race. African American patients continued to do worse in a contemporary Surveillance, Epidemiology, and End Results data set, because of increased association with T2 disease, older age, squamous histology, male sex, and suboptimal treatment.

KW - Access

KW - Race

KW - SBRT

KW - SEER

KW - Surgery

UR - http://www.scopus.com/inward/record.url?scp=85059871566&partnerID=8YFLogxK

UR - http://www.scopus.com/inward/citedby.url?scp=85059871566&partnerID=8YFLogxK

U2 - 10.1016/j.cllc.2018.11.004

DO - 10.1016/j.cllc.2018.11.004

M3 - Article

C2 - 30655194

AN - SCOPUS:85059871566

VL - 20

SP - 194

EP - 200

JO - Clinical Lung Cancer

JF - Clinical Lung Cancer

SN - 1525-7304

IS - 3

ER -